{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:28:56Z","timestamp":1777969736908,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nucmedbio.2026.109607","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:23:02Z","timestamp":1769214182000},"page":"109607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of an automated one-step radiolabeling procedure for a PSMA-targeted radiotherapeutic for prostate cancer"],"prefix":"10.1016","volume":"154-155","author":[{"given":"Meltem","family":"Ocak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanishka","family":"Sikligar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khanh-Van","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie N.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody D.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter N.","family":"Bomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford E.","family":"Berkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice C.","family":"Langton-Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nucmedbio.2026.109607_bb0005","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.7150\/thno.92612","article-title":"PSMA-targeted radiotheranostics in modern nuclear medicine: then, now, and what of the future?","volume":"14","author":"Sallam","year":"2024","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.nucmedbio.2026.109607_bb0010","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.7150\/thno.18719","article-title":"177Lu-labeled phosphoramidate-based PSMA inhibitors: the effect of an albumin binder on biodistribution and therapeutic efficacy in prostate tumor-bearing mice","volume":"7","author":"Choy","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.nucmedbio.2026.109607_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11307-019-01404-8","article-title":"Preclinical dosimetry, imaging, and targeted radionuclide therapy studies of Lu-177-labeled albumin-binding, PSMA-targeted CTT1403","volume":"22","author":"Ling","year":"2020","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2026.109607_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10967-019-06573-y","article-title":"Maintaining radiochemical purity of [177Lu]Lu-DOTA-PSMA-617 for PRRT by reducing radiolysis","volume":"321","author":"de Zanger","year":"2019","journal-title":"J Radioanal Nucl Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2026.109607_bb0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13139-022-00778-y","article-title":"Preparation of patient doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with carrier added (CA) and no carrier added (NCA) 177Lu","volume":"56","author":"Nanabala","year":"2022","journal-title":"Nucl Med Mol Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2026.109607_bb0030","first-page":"590","article-title":"Interim assessment of kidney dosimetry and pharmacokinetics in a phase I study of CTT1403, a novel 177Lu-labeled small molecule inhibitor of prostate specific membrane antigen","volume":"61","author":"Seo","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2026.109607_bb0035","author":"ClinicalTrials.gov"},{"issue":"9","key":"10.1016\/j.nucmedbio.2026.109607_bb0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2967\/jnumed.124.267667","article-title":"Single chelator-minibody theranostic agents for 89Zr PET imaging and 177Lu radiopharmaceutical therapy of PSMA-expressing prostate cancer","volume":"65","author":"Ho","year":"2024","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.nucmedbio.2026.109607_bb0045","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/molecules28041884","article-title":"Radiolysis-associated decrease in radiochemical purity of 177Lu-radiopharmaceuticals and comparison of the effectiveness of selected quenchers against this process","volume":"28","author":"Larenkov","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2026.109607_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.apradiso.2012.09.010","article-title":"Automation synthesis modules review","volume":"76","author":"Boschi","year":"2013","journal-title":"Appl Radiat Isot"},{"issue":"4","key":"10.1016\/j.nucmedbio.2026.109607_bb0055","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/molecules25040966","article-title":"A step-by-step guide for the novel radiometal production for medical applications: case studies with 68Ga, 44Sc, 177Lu and 161Tb","volume":"25","author":"Talip","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2026.109607_bb0060","series-title":"Clinical PET: Principles and Applications","first-page":"92","article-title":"Automated synthesis of radiopharmaceuticals","author":"Yang","year":"2004"},{"issue":"8","key":"10.1016\/j.nucmedbio.2026.109607_bb0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jlcr.3846","article-title":"Automated synthesis of 68Ga\/177Lu-PSMA on the Trasis miniAllinOne","volume":"63","author":"S\u00f8rensen","year":"2020","journal-title":"J Labelled Comp Radiopharm"},{"issue":"2","key":"10.1016\/j.nucmedbio.2026.109607_bb0070","first-page":"107","article-title":"Lutetium-177 DOTATATE production with an automated radiopharmaceutical synthesis system","volume":"3","author":"Aslani","year":"2015","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"8","key":"10.1016\/j.nucmedbio.2026.109607_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ph15080958","article-title":"Automated radiosynthesis, preliminary in vitro\/in vivo characterization of OncoFAP-based radiopharmaceuticals for cancer imaging and therapy","volume":"15","author":"Bartoli","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.nucmedbio.2026.109607_bb0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jlcr.3889","article-title":"Automated radiosynthesis of [68Ga]Ga-PSMA-11 and [177Lu]Lu-PSMA-617 on the iPHASE MultiSyn module for clinical applications","volume":"64","author":"Wichmann","year":"2021","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.nucmedbio.2026.109607_bb0085","article-title":"A scalable protocol for the radiosynthesis of clinical grade lutetium-177-labeled theranostic agents","author":"Hunt","year":"2025","journal-title":"Nat Protoc"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805126000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:10:02Z","timestamp":1777968602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805126000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":17,"alternative-id":["S0969805126000065"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109607","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an automated one-step radiolabeling procedure for a PSMA-targeted radiotherapeutic for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2026.109607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109607"}}